Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.21.2
Stock Based Compensation (Details) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2021
Number of shares    
Number of shares, Beginning balance 16,218,326 16,218,326
Number of shares, Grants   0
Number of shares, Exercises   150,000
Number of shares, Expiration   0
Number of shares, Ending balance 16,218,326 16,068,326
Options exercisable, Ending balance   16,068,326
Weighted Average Exercise Price    
Weighted Average Exercise Price, Beginning balance $ 0.50 $ 0.50
Weighted Average Exercise Price, Exercises   0.75
Weighted Average Exercise Price, Ending balance $ 0.50 0.49
Options exercisable, Ending balance   $ 0.49
Weighted Average Remaining Contractual Life (years)    
Weighted Average Remaining Contractual Life (years), Beginning balance   3 years 6 months 25 days
Weighted Average Remaining Contractual Life (years), Ending balance   3 years 1 month 6 days
Options exercisable, Ending balance   3 years 1 month 6 days
Aggregate Intrinsic Value    
Aggregate Intrinsic Value, Beginning balance   $ 3,588,631
Aggregate Intrinsic Value, Ending balance   8,720,095
Options exercisable, Ending balance, Intrinsic value   $ 8,720,095